Decreased somatostatin-like immunoreactivity in cerebral cortex and cerebrospinal fluid in Alzheimer's disease
- 1 January 1987
- journal article
- research article
- Published by Elsevier in Brain Research
- Vol. 402 (1) , 103-108
- https://doi.org/10.1016/0006-8993(87)91052-3
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Homovanillic acid and 5-hydroxyindoleacetic acid levels in cerebrospinal fluid of patients with senile dementia of Alzheimer typeActa Neurologica Scandinavica, 2009
- Decreased muscarinic receptor binding in cerebral cortex and hippocampus in alzheimer's diseaseLife Sciences, 1987
- Neurochemical Studies of Early-Onset Alzheimer's DiseaseNew England Journal of Medicine, 1985
- Evaluation of an Analogue of Somatostatin (L363,586) in Alzheimer's DiseaseNew England Journal of Medicine, 1985
- Low levels of somatostatin in human CSF mark depressive episodesPsychoneuroendocrinology, 1984
- Reduced lumbar CSF somatostatin in levels in Alzheimer's diseaseLife Sciences, 1982
- Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal ForebrainScience, 1982
- Clinical and Etiological Aspects of Senile DementiaEuropean Neurology, 1981
- The Origin of Cerebrospinal Fluid Somatostatin: Hypothalamic or Disperse Central Nervous System Secretion?Neuroendocrinology, 1981
- CHEMICAL PATHOLOGY OF THE ORGANIC DEMENTIASBrain, 1977